622 related articles for article (PubMed ID: 25703054)
41. A C-terminal glycine suppresses production of pleurocidin as a fusion peptide in Escherichia coli.
Bryksa BC; MacDonald LD; Patrzykat A; Douglas SE; Mattatall NR
Protein Expr Purif; 2006 Jan; 45(1):88-98. PubMed ID: 15935695
[TBL] [Abstract][Full Text] [Related]
42. An efficient procedure for the expression and purification of HIV-1 protease from inclusion bodies.
Nguyen HL; Nguyen TT; Vu QT; Le HT; Pham Y; Trinh PL; Bui TP; Phan TN
Protein Expr Purif; 2015 Dec; 116():59-65. PubMed ID: 26231073
[TBL] [Abstract][Full Text] [Related]
43. Expression and purification of the recombinant diphtheria fusion toxin DT388IL3 for phase I clinical trials.
Urieto JO; Liu T; Black JH; Cohen KA; Hall PD; Willingham MC; Pennell LK; Hogge DE; Kreitman RJ; Frankel AE
Protein Expr Purif; 2004 Jan; 33(1):123-33. PubMed ID: 14680969
[TBL] [Abstract][Full Text] [Related]
44. Refolding and purification of cGMP-grade recombinant human neurturin from Escherichia coli inclusion bodies.
Xi G; Esfandiary R; Sacramento CB; Jouihan H; Sharma A; Roth R; Linke T
Protein Expr Purif; 2020 Apr; 168():105552. PubMed ID: 31866372
[TBL] [Abstract][Full Text] [Related]
45. High-level production and one-step purification of biologically active human growth hormone in Escherichia coli.
Mukhija R; Rupa P; Pillai D; Garg LC
Gene; 1995 Nov; 165(2):303-6. PubMed ID: 8522194
[TBL] [Abstract][Full Text] [Related]
46. One-pot refolding of core histones from bacterial inclusion bodies allows rapid reconstitution of histone octamer.
Lee YT; Gibbons G; Lee SY; Nikolovska-Coleska Z; Dou Y
Protein Expr Purif; 2015 Jun; 110():89-94. PubMed ID: 25687285
[TBL] [Abstract][Full Text] [Related]
47. Expression, refolding, and characterization of human soluble BAFF synthesized in Escherichia coli.
Cao P; Mei JJ; Diao ZY; Zhang Sq
Protein Expr Purif; 2005 May; 41(1):199-206. PubMed ID: 15802238
[TBL] [Abstract][Full Text] [Related]
48. Improved procedure for a high-yield recovery of enzymatically active recombinant calf chymosin from Escherichia coli inclusion bodies.
Tichý PJ; Kaprálek F; Jecmen P
Protein Expr Purif; 1993 Feb; 4(1):59-63. PubMed ID: 8425109
[TBL] [Abstract][Full Text] [Related]
49. Rational recombinant XMRV antigen preparation and bead coupling for multiplex serology in a suspension array.
Sheikholvaezin A; Blomberg F; Ohrmalm C; Sjösten A; Blomberg J
Protein Expr Purif; 2011 Dec; 80(2):176-84. PubMed ID: 21871964
[TBL] [Abstract][Full Text] [Related]
50. Expression, refolding and purification of Ov-GRN-1, a granulin-like growth factor from the carcinogenic liver fluke, that causes proliferation of mammalian host cells.
Smout MJ; Mulvenna JP; Jones MK; Loukas A
Protein Expr Purif; 2011 Oct; 79(2):263-70. PubMed ID: 21757010
[TBL] [Abstract][Full Text] [Related]
51. Production of recombinant Chikungunya virus envelope 2 protein in Escherichia coli.
Tripathi NK; Priya R; Shrivastava A
Appl Microbiol Biotechnol; 2014 Mar; 98(6):2461-71. PubMed ID: 24337252
[TBL] [Abstract][Full Text] [Related]
52. Expression, refolding, and characterization of recombinant thrombopoietin/stem cell factor fusion protein in Escherichia coli.
Zang Y; Zhang X; Jiang X; Li H; Zhu J; Zhang C; Peng W; Qin J
Appl Microbiol Biotechnol; 2007 Mar; 74(4):836-42. PubMed ID: 17123074
[TBL] [Abstract][Full Text] [Related]
53. Expression, purification, and therapeutic implications of recombinant sFRP1.
Ghoshal A; Ghosh SS
Appl Biochem Biotechnol; 2015 Feb; 175(4):2087-103. PubMed ID: 25432334
[TBL] [Abstract][Full Text] [Related]
54. Development of a simple fed-batch process for the high-yield production of recombinant Japanese encephalitis virus protein.
Tripathi NK; Shukla J; Biswal KC; Lakshmana Rao PV
Appl Microbiol Biotechnol; 2010 May; 86(6):1795-803. PubMed ID: 20177885
[TBL] [Abstract][Full Text] [Related]
55. Solubilization of inclusion body proteins using n-propanol and its refolding into bioactive form.
Singh SM; Sharma A; Upadhyay AK; Singh A; Garg LC; Panda AK
Protein Expr Purif; 2012 Jan; 81(1):75-82. PubMed ID: 21964443
[TBL] [Abstract][Full Text] [Related]
56. Soybean disease resistance protein RHG1-LRR domain expressed, purified and refolded from Escherichia coli inclusion bodies: preparation for a functional analysis.
Afzal AJ; Lightfoot DA
Protein Expr Purif; 2007 Jun; 53(2):346-55. PubMed ID: 17287130
[TBL] [Abstract][Full Text] [Related]
57. Enhancement of 5-aminolevulinate production with recombinant Escherichia coli using batch and fed-batch culture system.
Fu W; Lin J; Cen P
Bioresour Technol; 2008 Jul; 99(11):4864-70. PubMed ID: 17993272
[TBL] [Abstract][Full Text] [Related]
58. Enhancement of solubility, purification and inclusion-bodies-refolding of an active pectin lyase from Penicillium occitanis expressed in Escherichia coli.
Hadj Sassi A; Trigui-Lahiani H; Abdeljalil S; Gargouri A
Int J Biol Macromol; 2017 Feb; 95():256-262. PubMed ID: 27845226
[TBL] [Abstract][Full Text] [Related]
59. Expression of fibronectin-binding protein of L. acidophilus NCFM and in vitro refolding to adhesion capable native-like protein from inclusion bodies.
Bisht S; Singh KS; Choudhary R; Kumar S; Grover S; Mohanty AK; Pande V; Kaushik JK
Protein Expr Purif; 2018 May; 145():7-13. PubMed ID: 29229289
[TBL] [Abstract][Full Text] [Related]
60. Development of a rapid high-efficiency scalable process for acetylated Sus scrofa cationic trypsin production from Escherichia coli inclusion bodies.
Zhao M; Wu F; Xu P
Protein Expr Purif; 2015 Dec; 116():120-6. PubMed ID: 26318238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
